PME share price is in focus.
Founded in 1983, Pro Medicus is a provider of radiology IT software serving hospitals, imaging centers and healthcare groups worldwide.
The company’s product portfolio focuses on radiology information systems (RIS), picture archiving and communication systems (PACS) and advanced visualization solutions. These tools support tasks ranging from patient scheduling and billing to rapid medical imaging interpretation and analysis.
ProMedics’ key value proposition lies in its flagship Visage software, which enables radiologists to remotely view large image files generated by X-rays on mobile devices. This capability allows diagnostic decisions to be made on the go, potentially improving patient outcomes by providing timely and accessible information.
ASX Healthcare Shares Appeal
gave S&P/ASX200 Healthcare Index (ASX: XHJ) is back. -9.15% Compared to the broader ASX 200 at 3.87% per annum each year over the past 5 years. There are three main reasons to consider adding a healthcare company like PME to your investment watchlist.
Sticky income
Health care costs are (in most cases) necessary expenses, making it one of the last areas people cut back on during tough economic times.
Unlike cyclical businesses affected by commodity prices or seasonal demand, healthcare companies benefit from stable and consistent revenue streams. We sometimes call this ‘sticky’ income. Evidence of this fact is that there was health care. Department of Excellence During the GFC.
Growth potential
Global healthcare spending, particularly in the US – which accounts for more than 40% of the global total – is expected to increase significantly. US growth is projected at 7% per annum from 2022 to 2027, reaching US$819 billion.
Within the broader healthcare sector, certain subsectors stand out for their potential for additional growth. For example, healthcare IT, data solutions, and ‘software-as-a-service’ (or SaaS) companies are forecast to grow their revenues at a rate of more than 15% per year from 2024 to 2030, a rate that will interest most investors.
Ethical investors
A recent one Morgan Stanley The survey revealed that more than half of investors plan to increase their allocation to sustainable investments in 2024. With increasing interest in ‘ethical’ and ‘sustainable’ investment, sectors such as healthcare that provide essential public services are well positioned to attract new capital and investors.
Determination of PME share price
As a growth company, one way to get a broad estimate on PME share price is to compare its price-to-sales multiple over time. Currently, shares of Pro Medicus Ltd trade at a price-to-sales ratio of 135.62x, compared to its 5-year average of 82.69x, meaning its shares are trading above their historical average. This may mean that the share price has increased, or that sales have decreased. In case of PME, the revenue has been increasing for the last 3 years.
Please keep in mind that context is important – and this is just one evaluation technique. Investment decisions cannot be based on just one metric.
Rask websites offer free online investing courses, created by analysts explaining things like discounted cash flow (DCF) and dividend discount models (DDM). They even include free valuation spreadsheets! Both these models will be a better way to value PME share price.
